Related Articles
Combined effect of (‑)‑epigallocatechin‑3‑gallate and all‑trans retinoic acid in <em>FLT3</em>‑mutated cell lines
The novel three‑way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3‑ITD mutation: A case report
Novel AXL‑targeted agents overcome FLT3 inhibitor resistance in FLT3‑ITD+ acute myeloid leukemia cells
Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells
High expression of FLT3 is a risk factor in leukemia